Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak

The multi-resistant yeast <i>Candida auris</i> has become a global public health threat because of its ease to persist and spread in clinical environments, especially in intensive care units. One of the most severe manifestations of invasive candidiasis is candidaemia, whose epidemiology...

Full description

Bibliographic Details
Main Authors: Juan V. Mulet Bayona, Nuria Tormo Palop, Carme Salvador García, Paz Herrero Rodríguez, Vicente Abril López de Medrano, Carolina Ferrer Gómez, Concepción Gimeno Cardona
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/9/558
_version_ 1797555093493514240
author Juan V. Mulet Bayona
Nuria Tormo Palop
Carme Salvador García
Paz Herrero Rodríguez
Vicente Abril López de Medrano
Carolina Ferrer Gómez
Concepción Gimeno Cardona
author_facet Juan V. Mulet Bayona
Nuria Tormo Palop
Carme Salvador García
Paz Herrero Rodríguez
Vicente Abril López de Medrano
Carolina Ferrer Gómez
Concepción Gimeno Cardona
author_sort Juan V. Mulet Bayona
collection DOAJ
description The multi-resistant yeast <i>Candida auris</i> has become a global public health threat because of its ease to persist and spread in clinical environments, especially in intensive care units. One of the most severe manifestations of invasive candidiasis is candidaemia, whose epidemiology has evolved to more resistant non-<i>albicans</i><i>Candida</i> species, such as <i>C. auris</i>. It is crucial to establish infection control policies in order to control an outbreak due to nosocomial pathogens, including the implementation of screening colonisation studies. We describe here our experience in managing a <i>C. auris</i> outbreak lasting more than two and a half years which, despite our efforts in establishing control measures and surveillance, is still ongoing. A total of 287 colonised patients and 47 blood stream infections (candidaemia) have been detected to date. The epidemiology of those patients with candidaemia and the susceptibility of <i>C. auris</i> isolates are also reported. Thirty-five patients with candidaemia (74.5%) were also previously colonised. Forty-three patients (91.5%) were hospitalised (61.7%) or had been hospitalised (29.8%) in the ICU before developing candidaemia. Antifungal therapy for candidaemia consisted of echinocandins in monotherapy or in combination with amphotericin B or isavuconazole. The most common underlying disease was abdominal surgery (29.8%). The thirty-day mortality rate was 23.4% and two cases of endophtalmitis due to <i>C. auris</i> were found. All isolates were resistant to fluconazole and susceptible to echinocandins and amphotericin B. One isolate became resistant to echinocandins two months after the first isolate. Although there are no established clinical breakpoints, minimum inhibitory concentrations for isavuconazole were low (≤ 1 μg/mL).
first_indexed 2024-03-10T16:42:33Z
format Article
id doaj.art-1215824b650e4caa9b9d6b7f69cc4921
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T16:42:33Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-1215824b650e4caa9b9d6b7f69cc49212023-11-20T11:53:11ZengMDPI AGAntibiotics2079-63822020-08-019955810.3390/antibiotics9090558Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> OutbreakJuan V. Mulet Bayona0Nuria Tormo Palop1Carme Salvador García2Paz Herrero Rodríguez3Vicente Abril López de Medrano4Carolina Ferrer Gómez5Concepción Gimeno Cardona6Microbiology Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, SpainMicrobiology Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, SpainMicrobiology Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, SpainInfectious Diseases Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, SpainInfectious Diseases Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, SpainAnestesiology and Reanimation Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia SpainMicrobiology Department, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, SpainThe multi-resistant yeast <i>Candida auris</i> has become a global public health threat because of its ease to persist and spread in clinical environments, especially in intensive care units. One of the most severe manifestations of invasive candidiasis is candidaemia, whose epidemiology has evolved to more resistant non-<i>albicans</i><i>Candida</i> species, such as <i>C. auris</i>. It is crucial to establish infection control policies in order to control an outbreak due to nosocomial pathogens, including the implementation of screening colonisation studies. We describe here our experience in managing a <i>C. auris</i> outbreak lasting more than two and a half years which, despite our efforts in establishing control measures and surveillance, is still ongoing. A total of 287 colonised patients and 47 blood stream infections (candidaemia) have been detected to date. The epidemiology of those patients with candidaemia and the susceptibility of <i>C. auris</i> isolates are also reported. Thirty-five patients with candidaemia (74.5%) were also previously colonised. Forty-three patients (91.5%) were hospitalised (61.7%) or had been hospitalised (29.8%) in the ICU before developing candidaemia. Antifungal therapy for candidaemia consisted of echinocandins in monotherapy or in combination with amphotericin B or isavuconazole. The most common underlying disease was abdominal surgery (29.8%). The thirty-day mortality rate was 23.4% and two cases of endophtalmitis due to <i>C. auris</i> were found. All isolates were resistant to fluconazole and susceptible to echinocandins and amphotericin B. One isolate became resistant to echinocandins two months after the first isolate. Although there are no established clinical breakpoints, minimum inhibitory concentrations for isavuconazole were low (≤ 1 μg/mL).https://www.mdpi.com/2079-6382/9/9/558<i>Candida auris</i>candidaemiafungiyeastoutbreakmultidrug-resistant
spellingShingle Juan V. Mulet Bayona
Nuria Tormo Palop
Carme Salvador García
Paz Herrero Rodríguez
Vicente Abril López de Medrano
Carolina Ferrer Gómez
Concepción Gimeno Cardona
Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak
Antibiotics
<i>Candida auris</i>
candidaemia
fungi
yeast
outbreak
multidrug-resistant
title Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak
title_full Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak
title_fullStr Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak
title_full_unstemmed Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak
title_short Characteristics and Management of Candidaemia Episodes in an Established <i>Candida auris</i> Outbreak
title_sort characteristics and management of candidaemia episodes in an established i candida auris i outbreak
topic <i>Candida auris</i>
candidaemia
fungi
yeast
outbreak
multidrug-resistant
url https://www.mdpi.com/2079-6382/9/9/558
work_keys_str_mv AT juanvmuletbayona characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak
AT nuriatormopalop characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak
AT carmesalvadorgarcia characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak
AT pazherrerorodriguez characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak
AT vicenteabrillopezdemedrano characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak
AT carolinaferrergomez characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak
AT concepciongimenocardona characteristicsandmanagementofcandidaemiaepisodesinanestablishedicandidaaurisioutbreak